Showing 1831-1840 of 4355 results for "".
Topical Rejuvenation Options for the Hyperpigmentation Patient
https://practicaldermatology.com/topics/general-topics/PD0609_03-php/22812/Appropriate rejuvenation regimens can actually correct hyperpigmentation and not make it worse.Mind Your Business: Exploring the Mind/Skin Connection
https://practicaldermatology.com/topics/general-topics/mind-your-business-exploring-the-mindskin-connection/20754/Dermatologists and mental health professionals can join forces to treat the whole patient.Case Report, Plus Top Resident Presentations from CSF 2014, and Ask an Expert
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-plus-top-resident-presentations-from-csf-2014-and-ask-an-expert/21226/New Products/New In My Practice: Devices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-productsnew-in-my-practice-devices-1/23438/Laser Scar Revision
https://practicaldermatology.com/issues/supplements/laser-scar-revision/21463/Experts discuss reimbursement issues, treatment protocols, combination therapy, as well as the future for scar revision therapy.Keep Your Dermatology Practice HIPAA Compliant With These 5 Photo Tips
https://practicaldermatology.com/topics/practice-management/keep-your-dermatology-practice-hipaa-compliant-with-these-5-photo-tips/20684/Recommendations for managing patient photos while preserving privacy.Transitioning a Medical Dermatology Practice to a Cosmetic Dermatology Practice
https://practicaldermatology.com/topics/practice-management/transitioning-a-medical-dermatology-practice-to-a-cosmetic-dermatology-practice/22077/The transition is natural for many practices. Key is to set and follow a plan.Dumbing Down of Dermatology By Evidence-Based Medicine
https://practicaldermatology.com/topics/practice-management/how-do-you-make-this-do-that/20593/GLP-1 Receptor Agonists and the Aesthetic Patient: Considerations for the Dermatologist
https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/The impact of glucagon-like peptide-1 agonists (GLP-1), such as semaglutide, tirzepatide and liraglutide, has transformed the healthcare industry and, in particular, aesthetic dermatology. The most common intended use of these medications, namely diabetes management and weight loss, can lead to a muCurrents: Targeted Opportunities
https://practicaldermatology.com/topics/practice-management/currents-targeted-opportunities/23097/Reach your goals in dermatology practice.